Treace Medical Concepts (TMCI) Non Operating Investment Income (2022 - 2026)
Treace Medical Concepts' (TMCI) quarterly Non Operating Investment Income came in at -$98000.0 in Q1 2026, down 145.0% YoY from $217777.8 in Q1 2025, and down 790.91% on a QoQ basis from -$11000.0 in Q4 2025.
Treace Medical Concepts (TMCI) Non Operating Investment Income (2022 - 2026) Analysis & Trends
Treace Medical Concepts (TMCI) has 5 years of Non Operating Investment Income data on file, last reported at -$98000.0 in Q1 2026.
- Quarterly Non Operating Investment Income fell 145.0% year-over-year to -$98000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$83000.0 (down 591.67% YoY) and the FY2025 annual result came in at -$25000.0, up 62.12% from the prior year.
- Non Operating Investment Income eased to -$98000.0 in Q1 2026, from -$11000.0 in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of $311000.0 in Q4 2023 to a low of -$163000.0 in Q2 2023.
- A 5-year average of -$1857.1 and a median of -$28000.0 in 2022 frame the typical range for Non Operating Investment Income.
- Annual changes were most pronounced in 2023 — Non Operating Investment Income soared 1251.85% — and 2024, when it plunged 224.14%.
- Tracing TMCI's Non Operating Investment Income over 5 years: stood at -$27000.0 in 2022, then soared by 1251.85% to $311000.0 in 2023, then plunged by 130.23% to -$94000.0 in 2024, then surged by 88.3% to -$11000.0 in 2025, then plunged by 790.91% to -$98000.0 in 2026.
- The last three Non Operating Investment Income figures came in at -$98000.0 (Q1 2026), -$11000.0 (Q4 2025), and $33000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | - |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | - |
| 10 | Treace Medical Concepts | 285.57 Mn | 239.95 Mn | 35.61 Mn | -26,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -26,000.00 |
| Jun 30, 2026 | -26,000.00 |
| Mar 31, 2026 | -98,000.00 |
| Mar 31, 2026 | -98,000.00 |
| Dec 31, 2025 | -11,000.00 |
| Dec 31, 2025 | -11,000.00 |
| Sep 30, 2025 | 33,000.00 |
| Sep 30, 2025 | 33,000.00 |
| Jun 30, 2025 | -7,000.00 |
| Jun 30, 2025 | -7,000.00 |
| Mar 31, 2025 | -40,000.00 |
| Mar 31, 2025 | -40,000.00 |
| Dec 31, 2024 | -94,000.00 |
| Dec 31, 2024 | -94,000.00 |
| Sep 30, 2024 | 217,000.00 |
| Sep 30, 2024 | 217,000.00 |
| Jun 30, 2024 | -95,000.00 |
| Jun 30, 2024 | -95,000.00 |
| Mar 31, 2024 | -94,000.00 |
| Mar 31, 2024 | -94,000.00 |